Evidence map›Paper›PMID 37328048›Full record

ArticleOsteoarthritis and cartilage2023

B cells in osteoarthritis: simply a sign or a target for therapy?

Kevin G Burt, Carla R Scanzello

Abstract readEditorialComment
In one paragraph

Article in Osteoarthritis and cartilage, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kevin G BurtUniversity of Pennsylvania Perelman School of Medicine, Department of Orthopaedic Surgery, Philadelphia, PA, USA; Corporal Michael J. Crescenz VA Medical Center, Translational Musculoskeletal Research Center, Philadelphia, PA, USA. Electronic address: kevin.burt@pennmedicine.upenn.edu.
Carla R ScanzelloCorporal Michael J. Crescenz VA Medical Center, Translational Musculoskeletal Research Center, Philadelphia, PA, USA; University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Philadelphia, PA, USA. Electronic address: cscanz@pennmedicine.upenn.edu.

Funding

Modulation of Inflammation in Osteoarthritis via CD14-mediated pattern recognitionR01AR075737 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Carla Rose Scanzello · 2020 to 2026
$2.8M
BCCMA: Cartilage Repair Strategies to Alleviate Arthritis Pain (Care AP): Targeting Pattern-Recognition to Reduce Pain-Related Pathology in OsteoarthritisI01BX004912 · VA · PHILADELPHIA VA MEDICAL CENTER · PI SCANZELLO, CARLA ROSE · 2022 to 2025
–
Tissue Engineered Total Disc Replacement in a Large Animal ModelI01RX002274 · VA · PHILADELPHIA VA MEDICAL CENTER · PI MAUCK, ROBERT L, SMITH, HARVEY E. · 2017 to 2025
–
Targeting Cellular Mechanosensing to Alleviate Joint Stiffness in Synovial FibrosisI21RX003854 · VA · PHILADELPHIA VA MEDICAL CENTER · PI SCANZELLO, CARLA ROSE · 2022 to 2024
–
BLRD VA I01 BX004912NIAMS NIH HHS R01 AR075737RRD VA I01 RX002274RRD VA I21 RX003854
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B-LymphocytesOsteoarthritisHumans

Identifiers

PMID37328048
PMCPMC10680778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.